Publications produced by the EDRN investigators.
The following is a list of publications authored by EDRN investigators. You may sort and filter the results by both author and journal.
2-D or not 2-D is there a fututre for 2-D gels in proteomics? Insights from the York proteomic meeting
2D Differential In-gel Electrophoresis (DIGE) for the Identification of Esophageal Squamous Cell Cancer-Specific Protein Markers
—Flaig M, Zhou G, Emmert-Buck MR, Chen S, Li H, Liotta LA, DeCamp D, Hu N, Gong Y, Zhao Y, Taylor PR, Petricoin III EF, Gillespie JW, Shu H
4-Aminobiphenyl is a major etiological agent of human bladder cancer: evidence from its DNA binding spectrum in human p53 gene
—Rom WN, Tang M-s, Hu W, Feng Z, Beland FA
[-2]proPSA for prostate cancer detection: an NCI Early Detection Research Network validation study.
—Feng Z, Wang Y, Partin AW, Kagan J, Chan DW, Thompson IM, Sokoll LJ, Sanda MG
A blood-based proteomic classifier for the molecular characterization of pulmonary nodules
—Chelsky D, Schirm M, Hayward C, Li XJ, Fong PY, Lamontagne J, McLean M, Law S, Dominguez M, Lee LW, Butler H, Kearney P, Gingras O, Vachani A, Hood L, Hunsucker SW, Price ND, Rom WN, Fang KC, Massion PP, Pass H, Allard R, Lam S
A data-analytic strategy for protein-biomarker discovery: profiling of high-dimensional proteomic data for cancer detection
—Feng Z, Wright G Jr, Qu Y, Adam B-L, Pepe M, Winget M, Thompson ML, Yasui Y, Potter JD, Thornquist M
A distinct repertoire of autoantibodies in hepatocellular carcinoma identified by proteomic analysis
—Hanash SM and Beretta L, Le Naour F, Brichory F, Misek DE, Brechot C
A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer.
—Laxman B, Cao J, Chinnaiyan AM, Yu J, Morris DS, Tsodikov A, Siddiqui J, Tomlins SA, Mehra R, Lonigro RJ, Wei JT
A founder mutation of the MSH2 gene and hereditary nonpolyposis colorectal cancer in the United States
—Franken P, Fodde R, Hampel H, de la Chapelle A, Barrows A, Coronel SM, Okimoto R, Wagnr A, van der Klift H, Sweet K, Wijnen J, Lynch JF, Lynch HT
A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer
—Berg CD; PLCO Project Team, Marrangoni AM, Zhang Z, Pinsky PF, Ransohoff DF, Lu KH, Symanowski JT, Lokshin AE, Zhu CS, Hartge P, Mor G, Skates SJ, Bast RC Jr, Cramer DW, Urban N, Ward DC, Srivastava S, Moore LE, Buys SS, Patriotis C, Sluss PM, Scholler N, Lomakin A, McIntosh MW, Fung ET, Vitonis A, Pfeiffer RM
A functional annotation of subproteomes in human plasma
—Chaerkady R, Gerszten RE, Wu H, Suresh S, Drwal G, Paik YK, Ping P, Pandey A, Kellmann M, Hancock WS, States DJ, Hanash SM, Peri S, Rekha B, Schulz-Knappe P, Wasinger V, Gronborg M, Menon R, Shet AS, Raftery M, Molina H, Creighton CJ, Omenn GS, Vondriska TM, Yang Z, Cho SY, Kwon MS, Gandhi TK
A functional link between adhesion and proteolysis in ovarian epithelial ovarian carcinoma cells
—Stack MS, Fishman DA, Kearns A, Bafetti LM
A genetic analysis of extinction: Trans-dominant loci regulate expression of liver-specific genes in hepatoma hybrid cells
—Killary AM, Fournier REK
A genome-wide search identifies epigenetic silencing of somatostatin, tachykinin-1, and five other genes in colon cancer.
—Cheng Y, Sato F, Wang S, Berki AT, Ito T, Cai K, Abraham JM, Kan T, Hamilton JP, Mantzur C, Mori Y, Paun B, Jin Z, Meltzer SJ.
A highly sensitive targeted mass spectrometric assay for quantification of AGR2 protein in human urine and serum
—Rodland KD, Qian WJ, Liu AY, Liu T, Shi T, Fillmore TL, Nicora CD, Gao Y, Su D, Kagan J, Chan DW, Smith RD, Srivastava S, Camp DG, Zhao R, Quek SI
A homozygous deletion on chromosome 3 in a small cell lung cancer cell line correlates with a region of tumor suppressor activity
—Hensel CH, Buchhagen D, Killary AM, Minna JD, Garcia DK, Naylor SL, Daly MC, Xiang R-H
A lung cancer protein database
—Tra, F., E., Puravs, Oh, Brichory, Beer, J., D. and Hanash S
A major lung cancer susceptibility locus maps to chromosome 6q23-25
—Liu Q, Kupert E, de Andrade M, Seminara D, Rothschild H, Lee J, Mandal D, Gaba C, Fain P, Franklin W, Schwartz AG, Petersen GM, Amos CI, Zeng D, Zhang Q, Minna J, Wiest JS, You M, Gazdar A, Klein C, Pinney SM, Anderson MW, Zhou X, Perez A, Slusser J, Bailey-Wilson JE, Coons T
A meeting of minds in proteomics
—Petricoin III E, Hanash S, Liotta L
A mesothelioma epidemic in Cappadocia: scientific developments and unexpected social outcomes
—Dogan AU, Steele I, Emri S, Carbone M, Pass HI, Tuncer M, Baris YI
The next EDRN Steering Committee Meeting will take place March 31st through April 2nd, 2015, in Atlanta, Georgia.